1. Home
  2. BMRN vs TKO Comparison

BMRN vs TKO Comparison

Compare BMRN & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$56.74

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

N/A

Current Price

$194.01

Market Cap

12.6B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BMRN
TKO
Founded
1996
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
12.6B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
BMRN
TKO
Price
$56.74
$194.01
Analyst Decision
Buy
Strong Buy
Analyst Count
28
22
Target Price
$90.78
★ $232.37
AVG Volume (30 Days)
★ 2.4M
1.1M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
N/A
★ 1.58%
EPS Growth
N/A
★ N/A
EPS
0.14
★ 3.80
Revenue
$1,313,646,000.00
★ $4,735,151,000.00
Revenue This Year
$20.05
$22.96
Revenue Next Year
$14.91
$1.48
P/E Ratio
$415.29
★ $52.75
Revenue Growth
★ 17.62
N/A
52 Week Low
$49.26
$170.14
52 Week High
$70.98
$226.94

Technical Indicators

Market Signals
Indicator
BMRN
TKO
Relative Strength Index (RSI) 48.45 61.05
Support Level $53.19 $192.64
Resistance Level $58.39 $199.20
Average True Range (ATR) 1.85 5.97
MACD 0.33 2.17
Stochastic Oscillator 63.97 76.32

Price Performance

Historical Comparison
BMRN
TKO

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.

Share on Social Networks: